STEVEN C QUAY

CIK 1008227 · President & CEO · last filed 2026-01-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$59.13M

Companies

3

Total Filings

32

Lifetime Open-Market Net

-$431.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ATOS President & CEO 367,826 $2.46 $904.9K -$7.7K 21 2026-01-30
MRNA Chairman and CSO 1,166,669 $49.91 $58.23M $0 2 2009-03-20
Adhera Therapeutics, Inc. (NSTK) Delisted Chairman and CEO 434,624 -$424.0K 9 2008-04-02

Recent Filings · Page 2 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-15 ATOS Mixed $0 EDGAR
2018-06-29 ATOS Grant (A) $0 EDGAR
2018-05-31 ATOS Buy (P) $0 EDGAR
2017-05-26 ATOS Grant (A) $0 EDGAR
2016-05-19 ATOS Grant (A) $0 EDGAR
2016-03-10 ATOS Buy (P) +15,000 $5.5K EDGAR
2016-02-17 ATOS Buy (P) +15,000 $8.0K EDGAR
2016-01-21 ATOS Buy (P) +50,000 $10.0K EDGAR
2015-03-18 ATOS Grant (A) $0 EDGAR
2013-10-03 ATOS Sell (S) −7,265 -$41.1K EDGAR
Showing 1120 of 32
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.